Neuroone Medical Technologies (NMTC) Net Cash Flow (2010 - 2026)

Neuroone Medical Technologies has disclosed Net Cash Flow across 17 years of filings, most recently posting -$757605.0 for Q1 2026.

• Quarterly Net Cash Flow fell 507.53% year-over-year to -$757605.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (up 233.14% YoY) and the FY2025 annual result came in at $5.1 million, up 232.31% from the prior year.
• Net Cash Flow grew to -$757605.0 in Q1 2026, from -$3.0 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $6.7 million in Q2 2025 and bottomed at -$3.5 million in Q4 2022.
• The 5-year median for Net Cash Flow is -$814678.0 (2024), against an average of -$787077.2.
• The widest YoY moves for Net Cash Flow: up 924.8% in 2025, down 823.81% in 2025.
• Neuroone Medical Technologies' Net Cash Flow stood at -$3.5 million in 2022, then grew by 24.37% to -$2.6 million in 2023, then soared by 87.67% to -$325692.0 in 2024, then sank by 823.81% to -$3.0 million in 2025, then surged by 74.82% to -$757605.0 in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered -$757605.0, -$3.0 million, and -$1.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.